Ayesha Younas
Papers
1
Total Citations
15
H-Index
1
About
Dr. Ayesha Younas is a pioneering researcher at the forefront of cancer nanomedicine, whose work is redefining the landscape of precision oncology. Her research centers on the evolution of smart drug delivery systems, from passive EPR-mediated accumulation to active ligand-targeting and personalized therapeutic platforms. In her landmark 2025 review, Dr. Younas synthesized decades of progress since the 1995 approval of Doxil®, charting a coherent path toward programmable nanomedicines that integrate diagnostics, therapy, and real-time monitoring. Though her most-cited paper has already garnered 15 citations in its first year—a testament to its immediate impact—her broader contributions include advancing the clinical translation of multifunctional nanoparticles and developing strategies to overcome biological barriers in solid tumors. Dr. Younas’s work bridges fundamental materials science with clinical application, offering a visionary roadmap for next-generation cancer treatments. Her research is essential reading for students and scientists seeking to understand how nanomedicine is transitioning from a passive delivery concept to an intelligent, adaptive therapeutic paradigm.
Research Focus
Key Achievements
Top Papers
- 1